articleJNCI Journal of the National Cancer InstituteAug 16, 2005BRONZE OA

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)

National Cancer Institute · Institut für Medizinische Biometrie, Informatik und Epidemiologie · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Despite years of research and hundreds of reports on tumor markers in oncology, the number of markers that have emerged as clinically useful is pitifully small. Often, initially reported studies of a marker show great promise, but subsequent studies on the same or related markers yield inconsistent conclusions or stand in direct contradiction to the promising results. It is imperative that we attempt to understand the reasons that multiple studies of the same marker lead to differing conclusions. A variety of methodologic problems have been cited to explain these discrepancies. Unfortunately, many tumor marker studies have not been reported in a rigorous fashion, and published articles often lack sufficient…

No related works found for this paper.

Funding